ProQR Therapeutics (PRQR) Cash from Operations Growth (5y) (2018 - 2026)
ProQR Therapeutics (PRQR) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | ProQR Therapeutics | 187.02 Mn | 94.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.51% |
| Dec 31, 2025 | -5.81% |
| Sep 30, 2025 | -4.52% |
| Jun 30, 2025 | -2.64% |
| Mar 31, 2025 | -305.12% |
| Dec 31, 2024 | -0.12% |
| Sep 30, 2024 | 8.40% |
| Jun 30, 2024 | 8.77% |
| Mar 31, 2024 | -4.12% |
| Dec 31, 2023 | -230.18% |
| Sep 30, 2023 | -9.22% |
| Jun 30, 2023 | -9.91% |
| Mar 31, 2023 | 1,949.63% |
| Dec 31, 2022 | -338.19% |
| Sep 30, 2022 | -1,639.43% |
| Jun 30, 2022 | -3.52% |
| Mar 31, 2022 | -349.71% |
| Dec 31, 2021 | 16.00% |
| Sep 30, 2021 | -258.07% |
| Dec 31, 2020 | 17.94% |